Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108821966B reveals a high-yield, non-toxic route for 3,3'-(1,4-phenylene) diglutaric acid using ethyl acetoacetate, offering significant cost reduction.
Patent CN109503593A details a scalable synthesis route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN106699628A reveals efficient levulinic acid conversion. Lower temperature, high yield pyrrolidone synthesis for reliable supply chain.
Patent CN115947759A reveals a one-pot Remdesivir synthesis reducing steps and cost. Discover supply chain advantages and high-purity manufacturing insights.
Novel route for Iopamidol production via acylated intermediate. High purity, reduced impurities, and cost-effective manufacturing for global supply chains.
Patent CN110092735B reveals a high-yield Negishi coupling route for Eluxadoline intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical clients.
Patent CN103626791B details a cost-effective Grignard route for high-purity 3-amino-4-fluorophenylboronic acid, offering supply chain stability and reduced manufacturing costs.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Novel catalytic hydrogenation route reduces impurities and enhances yield for high-purity 3-aminosalicylic acid manufacturing supply chain stability.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN112724189A details a novel semi-synthetic route for Chenodeoxycholic Acid from waste bile acids, offering significant cost reduction and supply chain stability for API manufacturers.
Novel furandione route offers 60.9% yield and 99.5% purity for obesity drug intermediate, ensuring scalable supply chain solutions.
Patent CN110423261B reveals a novel synthesis route for 7-ketolithocholic acid from hyocholic acid, offering high purity and significant cost reduction in bile acid manufacturing.
Patent CN111777520B reveals a safe, high-yield synthesis route for dimethylamino phenyl acetic acid intermediates, offering significant cost and safety advantages.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN102241614B details a phosphotungstic acid catalyzed method for N-alkyl amides offering significant supply chain stability and cost reduction advantages.
Novel patent CN107629014A offers mild conditions for triazole intermediate production ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Discover the novel two-step synthesis of polysubstituted tetrahydrofuran dienoids from patent CN112142694A. Achieve cost reduction in pharmaceutical intermediate manufacturing with high yields.